Evaluation of improved coronary flow velocity reserve using transthoracic Doppler echocardiography after single LDL apheresis

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 5, 2004, Pages 383-389

  Kobayashi, Kengo ^a   Yamashita, Kazuhito ^a   Tasaki, Hiromi ^a   Suzuka, Hiroshi ^a   Nihei, Shun Ichi ^a   Ozumi, Kiyoshi ^a   Nakashima, Yasuhide ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Coronary flow velocity reserve; Low density lipoprotein apheresis; Transthoracic Doppler echocardiography

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ADENOSINE DIPHOSPHATE; AMLODIPINE; ATORVASTATIN; BRADYKININ; CALCIUM ANTAGONIST; ENDOTHELIUM DERIVED RELAXING FACTOR; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADULT; AGED; APHERESIS; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; EVALUATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOREARM BLOOD FLOW; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROVASCULARIZATION; PLASMA VISCOSITY; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; BLOOD FLOW VELOCITY; CHOLESTEROL, LDL; CORONARY VESSELS; CYTAPHERESIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 10044225915     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2004.00172.x     Document Type: Article

References (25)

1. Levine GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 1995;332:512-21.
2. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
3. Pitkanen OP, Raitakari OT, Niinikoski H et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 1996;28:1705-11.
4. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-93.
5. Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 1999;99:2871-5.
6. Thompson GR, Maher VM, Matthews S et al. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet 1995;345:811-6.
7. Mabuchi H, Koizumi J, Shimizu M et al. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group. Am J Cardiol 1998;82:1489-95.
8. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997;95:76-82.
9. Aengevaeren WR, Kroon AA, Stalenhoef AF, Uijen GJ, van der Werf T. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS). J Am Coll Cardiol 1996;28:1696-704.
10. Kroon AA, Aengevaeren WR, van der Werf T et al. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996;93:1826-35.
11. Mellwig KP, Baller D, Gleichmann U et al. Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis 1998;139:173-8.
12. Kojima S, Ogi M, Sugi T, Matsumoto Y, Yoshitomi Y, Kuramochi M. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis. Ther Apher 1997;1:356-61.
13. Hozumi T, Yoshida K, Akasaka T et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 1998;32:1251-9.
14. Kohno H, Yamada H, Azuma A et al. [Measurement of coronary flow reserve using adenosine 5′-triphosphate in dogs]. J Cardiol 1998;32:1-8. (In Japanese.)
15. Jones CJ, Kuo L, Davis MJ, DeFily DV, Chilian WM. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 1995;91:1807-13.
16. Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 1995;92:2135-41.
17. Caiati C, Montaldo C, Zedda N, Bina A, Iliceto S. New non-invasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 1999;99:771-8.
18. - levels in patients with hypercholesterolemia. Atherosclerosis 1996;127:43-7.
19. Anderson HV, Stokes MJ, Leon M, Abu-Halawa SA, Stuart Y, Kirkeeide RL. Coronary artery flow velocity is related to lumen area and regional left ventricular mass. Circulation 2000;102:48-54.
20. Duffy SJ, Castle SF, Harper RW, Meredith IT. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation 1999;100:1951-7.
21. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993;88:43-54.
22. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160-2.
23. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990;86:75-9.
24. Griffith TM, Edwards DH. Myogenic autoregulation of flow may be inversely related to endothelium-derived relaxing factor activity. Am J Physiol 1990;258:H1171-80.
25. Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984-92.